Grindeks

About Grindeks

JSC "Grindeks" is a vertically integrated pharmaceutical company based in Riga, the Baltics,  with the history from 1946. Its main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The company specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups. Currently "Grindeks" produces 23 APIs.  Products are exported to 87 countries and the key markets include the EU countries, the U.S.A., Canada, Japan, Russia and other CIS countries, Vietnam.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • LV
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Contact info
Show contact info Hide contact info

Products from Grindeks (5)

  • Grindeks API portfolio

    Product Grindeks API portfolio

    Please see Grindeks up-to-date Active Pharmaceutical Ingredient (API) product portfolio in the link attached: https://grindeks.com/en/products/active-pharmaceutical-ingredients/
  • Grindeks FDF portfolio

    Product Grindeks FDF portfolio

    Please see Grindeks up-to-date Final Dosage Form (FDF) product portfolio, including pipeline products, in the link attached. Dossiers are harmonized according to ICH and EMA requirements. https://grindeks.com/en/products/final-dosage-forms/
  • Fentanyl

    Product Fentanyl

    Opioid
  • Levosimendan

    Product Levosimendan

    Cardiac therapy
  • Xylazine

    Product Xylazine

    Sedative, analgesic, muscle relaxant

Grindeks Resources (1)

  • JSC Grindeks FDF Portfolio

    Brochure JSC Grindeks FDF Portfolio

    Sold in 87 countries worldwide, Grindeks' International product portfolio is successfully composed of generic medications, all produced in line with the world class requirements of safety and quality. We are continuously developing new FDF products and these will be added to the list below on a regular base.